Kyverna Therapeutics, Inc. KYTX Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Kyverna Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s interest coverage?
- Kyverna Therapeutics, Inc. (KYTX) reported interest coverage of -144.7× in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s interest coverage changed year-over-year?
- Kyverna Therapeutics, Inc.'s interest coverage increased by 88.9% year-over-year, from -1,306.1× to -144.7×.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s interest coverage?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s interest coverage has grown at a 1.9% compound annual growth rate (CAGR), from -333.7× to -346.6×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.